ao-128 and Glycogen-Storage-Disease-Type-I

ao-128 has been researched along with Glycogen-Storage-Disease-Type-I* in 1 studies

Other Studies

1 other study(ies) available for ao-128 and Glycogen-Storage-Disease-Type-I

Article	Year
Prevention of hypoglycaemia in a patient with type Ib glycogen storage disease by an amylase (alpha-glucosidase) inhibitor. Acta paediatrica (Oslo, Norway : 1992), 1998, Volume: 87, Issue:5 Patients with type Ib glycogen storage disease (GSD Ib) are susceptible to hypoglycaemic episodes. To determine whether an amylase (alpha-glucosidase) inhibitor, voglibose, can be useful in the control of hypoglycaemia, we tried it in a 14-y-old male with GSD Ib. Oral administration of voglibose prolonged the duration of normoglycaemia and reduced the incidence of hypoglycaemia attacks. These findings indicate that voglibose may be useful for preventing hypoglycaemia in GSD Ib patients. Topics: Adolescent; Blood Glucose; Glycogen Storage Disease Type I; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemia; Inositol; Male	1998

Article

Year

Prevention of hypoglycaemia in a patient with type Ib glycogen storage disease by an amylase (alpha-glucosidase) inhibitor.

Acta paediatrica (Oslo, Norway : 1992), 1998, Volume: 87, Issue:5

Patients with type Ib glycogen storage disease (GSD Ib) are susceptible to hypoglycaemic episodes. To determine whether an amylase (alpha-glucosidase) inhibitor, voglibose, can be useful in the control of hypoglycaemia, we tried it in a 14-y-old male with GSD Ib. Oral administration of voglibose prolonged the duration of normoglycaemia and reduced the incidence of hypoglycaemia attacks. These findings indicate that voglibose may be useful for preventing hypoglycaemia in GSD Ib patients.

Topics: Adolescent; Blood Glucose; Glycogen Storage Disease Type I; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemia; Inositol; Male

1998